Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CMC PHARMACEUTICALS, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2023-06-27 to 2025-07-02
Current total value of award: $662558.64
Description: PHASE II - BASE YEAR